Keeping it real! What could possibly go wrong when you trust pharmaceutical weight loss injections or drugs into your body? Paralysis of abdomen, paralysis of brain and other organs and CNS? Trust one thing that’s nothing about GLP-1! Excerpt : "To say I had an adverse reaction would be somewhat of an understatement," she wrote. "Explosive, uncontrollable diarrhea. Sulfur burps so violent they left me afraid to open my mouth in public. Sneezing attacks every time I tried to eat or drink — which apparently has a name, snatiation. Cramping. Bloating. Full-body aching, as though I had the flu. And an inability to keep down even small sips of water without sprinting to the bathroom with yet more explosive diarrhea. More than three times, I didn't make it." At one point, Bialik wrote, her symptoms got so bad, a nurse had to come to her home and administer IV fluids. "What shocked me was how unsurprised my doctor and this nurse seemed," Bialik added. "How could a reaction even half as severe as mine be considered normal?" The risks and benefits of GLP-1s Though GLP-1s have helped many people reclaim their health, the drugs aren't without the risks. According to Mayo Clinic, gastrointestinal issues remain among the most commonly reported side effects, including nausea, vomiting, diarrhea, constipation, bloating and stomach discomfort. Fatigue, dizziness, headaches and redness or itching around the injection site are also side effects

Keeping it real!  What could possibly go wrong when you trust pharmaceutical weight loss injections or drugs into your body? Paralysis of abdomen, paralysis of brain and other organs and CNS?  Trust one thing that’s nothing about GLP-1! 

Deadly Symptoms Never Go Away!

Excerpt :


"To say I had an adverse reaction would be somewhat of an understatement," she wrote. "Explosive, uncontrollable diarrhea. Sulfur burps so violent they left me afraid to open my mouth in public. Sneezing attacks every time I tried to eat or drink — which apparently has a name, snatiation. Cramping. Bloating. Full-body aching, as though I had the flu. And an inability to keep down even small sips of water without sprinting to the bathroom with yet more explosive diarrhea. More than three times, I didn't make it."
At one point, Bialik wrote, her symptoms got so bad, a nurse had to come to her home and administer IV fluids.
"What shocked me was how unsurprised my doctor and this nurse seemed," Bialik added. "How could a reaction even half as severe as mine be considered normal?"
The risks and benefits of GLP-1s
Though GLP-1s have helped many people reclaim their health, the drugs aren't without the risks. According to Mayo Clinic, gastrointestinal issues remain among the most commonly reported side effects, including nausea, vomiting, diarrhea, constipation, bloating and stomach discomfort. Fatigue, dizziness, headaches and redness or itching around the injection site are also side effects.
Other side effects, according to Mayo Clinic, include loss of muscle mass and reduced bone density. Rare but more serious risks are pancreatitis, gallbladder disease, acute kidney injury and thyroid C-cell changes, which have been seen in animal studies.

https://kidsworldplus.blogspot.com/2026/06/keeping-it-real-what-could-possibly-go.html?m=1


Mayim Bialik went on a GLP-1. It was a 'nightmare'



🌿 All purchases of books and journals support and help the life work of international educator, author and artist Laurel Sobol https://www.barnesandnoble.com/search?q=Laurel%20Sobol ~

 All books by Laurel Sobol available Online at Barns and Noble Books ♥️Oregon Author ♥️Mom Homeschooler ♥️American Business Woman ♥️American ArtistPoet ♥️The Magical Fairytales ♥️OLT Organic Lifestyle Today ♥️Nez PerceπŸ“š ♥️Mysteries Of Topanga Canyon ♥️Little House Of Miracles Barnes and Noble


⭐️⭐️⭐️ 




USA TODAY

Mayim Bialik went on a GLP-1. It was a 'nightmare'

Charles Trepany, USA TODAY
4 min read

Mayim Bialik is sharing her "nightmare" experience on a GLP-1 medication.

In a piece published in The Free Press on June 5, titled "Mayim Bialik: My GLP-1 Nightmare," the "Big Bang Theory" star and former "Jeopardy!"host, 50, opened up about going on a weight-loss medication after a doctor told her it might alleviate her symptoms from Graves' disease, an autoimmune condition.

"I was exhausted from being sick, from the endless parade of specialists, from the diets, the protocols, and the promises," Bialik wrote of her experience with Graves' disease. "Maybe this could be the magic cure."

But it wasn't. Instead, she wrote, the medication gave her intense gastrointestinal issues which made her "too sick to stand, drink water, or think straight." Bialik did not name which specific GLP-1 medication she went on in the piece.

Unfortunately, Bialik isn't alone − for some, GLP-1 medications have caused negative side effects, particularly gastrointestinal issues. Still, the drugs have been lifelines for others, vastly improving their health overall. Here's what Bialik said about her experience and what to know about the pros and cons associated with GLP-1s.

Mayim Bialik attends the "Doctor Strange In The Multiverse Of Madness" premiere on May 2, 2022.
Mayim Bialik attends the "Doctor Strange In The Multiverse Of Madness" premiere on May 2, 2022.

Mayim Bialik went on a GLP-1. For her, it was a nightmare.

Bialik wrote that she was familiar with GLP-1s prior to starting one, thanks to social media advertisements, influencers touting them and a plethora of online services offering compounded versions of the medications.

Bialik wrote that her side effects were intense and gave her deeper empathy for those living with Crohn's disease, irritable bowel syndrome, colitis and other gastrointestinal conditions.


Mayim Bialik, other celebs are doing hyperbaric oxygen therapy. What is it?

"To say I had an adverse reaction would be somewhat of an understatement," she wrote. "Explosive, uncontrollable diarrhea. Sulfur burps so violent they left me afraid to open my mouth in public. Sneezing attacks every time I tried to eat or drink — which apparently has a name, snatiation. Cramping. Bloating. Full-body aching, as though I had the flu. And an inability to keep down even small sips of water without sprinting to the bathroom with yet more explosive diarrhea. More than three times, I didn't make it."

At one point, Bialik wrote, her symptoms got so bad, a nurse had to come to her home and administer IV fluids.

"What shocked me was how unsurprised my doctor and this nurse seemed," Bialik added. "How could a reaction even half as severe as mine be considered normal?"

The risks and benefits of GLP-1s

Though GLP-1s have helped many people reclaim their health, the drugs aren't without the risks. According to Mayo Clinic, gastrointestinal issues remain among the most commonly reported side effects, including nausea, vomiting, diarrhea, constipation, bloating and stomach discomfort. Fatigue, dizziness, headaches and redness or itching around the injection site are also side effects.

Other side effects, according to Mayo Clinic, include loss of muscle mass and reduced bone density. Rare but more serious risks are pancreatitis, gallbladder disease, acute kidney injury and thyroid C-cell changes, which have been seen in animal studies.

There's a big Ozempic controversy brewing online. Doctors say it's the 'wild west.'

The medications, while revolutionary, are not a one-size-fits-all solution, Mayo Clinic says. For those interested in going on a GLP-1, it's crucial to talk to your doctor to get a comprehensive view of your health, assess the risks and decide if this medication is right for you.

However, in an era where so many are clamoring for these drugs − and will do anything to get their hands on them − not everyone is following appropriate medical guidance.

"Even in my social circle, I have friends who (say they) got 'the fat drug' off of a website, and I just rail inside,"  Dr. Britta Reierson, a board-certified family physician and obesity medicine specialist at the healthcare company Knownwell, previously told USA TODAY. "I'm just seething inside just knowing that A, I know they're not taking it for the right reasons, and B, this might not be safe for them."

Taking Ozempic for weight loss? You might find other benefits, too - and a few risks

A study published last year became the first to catalogue the risks and benefits of GLP-1s. It confirmed that the drugs are associated with a lower risk of heart attack, stroke and other cardiovascular problems. People who took them also had fewer seizures and addictions to alcohol, cannabis and opioids.

On the flip side, the study also found GLP-1s are associated with an increased risk of several negative health outcomes and side effects. The most common were the well-known gastrointestinal problems, such as nausea, vomiting, diarrhea and gastroparesis, or stomach paralysis.


Contributing; Adrianna Rodriguez

This article originally appeared on USA TODAY: Mayim Bialik's GLP-1 'nightmare' and what to know about side effects

Explore related articles

Business

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

NEW YORK, June 6 (Reuters) - Pfizer presented data on Saturday that showed a monthly dose of an experimental obesity drug it acquired through its purchase of ‌Metsera last year had a similar side-effect profile as rival Novo Nordisk's weekly injection Wegovy. The ‌drugmaker hopes the compound, called berobenatide, can be the first GLP-1 weight-loss drug offered as a monthly shot as the ​company works to differentiate the compound from blockbuster drugs like Wegovy and Eli Lilly's Zepbound.

Reuters2 min read
Business

Novo Nordisk Eyes Next GLP 1 Wave With Amycretin Trial Results

Novo Nordisk (CPSE:NOVO B) reported positive phase 2 data for its investigational drug amycretin (zenagamtide), a dual GLP-1 and amylin receptor agonist. The phase 2 trial in adults with type 2 diabetes showed strong glycemic control and significant weight loss, with no clear plateau at higher doses. Safety and efficacy data support moving amycretin into phase 3 trials for both diabetes and obesity. This is the first major update on this new pipeline candidate as Novo Nordisk seeks to...

Simply Wall St.4 min read
Business

How grocers are catering to GLP-1 users

Weight loss medications have changed the game of health and wellness. From protein-focused private label to wellness guides, here’s how grocers are keeping up.

Grocery Dive3 min read
Health

Why Weight Loss Efforts Can Sometimes Lead to Constipation and Digestive Changes

Whether you’re cutting calories, swapping out processed foods or just eating less than your body is used to, constipation is one of the most common — and least talked about — side effects of any weight loss journey. The good news is that the same fixes doctors give to patients on prescription medications like Ozempic

Woman's World3 min read
Health

4 Serious PPI Side Effects You Need To Know Before Your Next Heartburn Dose

You deserve to eat what you love without the searing pain of heartburn—and meds like Prilosec, Nexium and Prevacid can help make that possible. Yet if you regularly take the little pills, called proton pump inhibitors or PPIs, doctors want you to be aware of potential PPI side effects. “We're talking about things like nutrient

Woman's World5 min read
Health

What Are Peptides? 5 ‘Miracle Molecules’ Women Over 50 Are Buzzing About

Peptides are popping up everywhere you look—from your favorite skincare brand to the grocery store aisle. These “miracle molecules” are being credited with everything from erasing wrinkles to healing your gut to helping you shed stubborn weight. But what are peptides, exactly? You may be surprised to learn you're probably already using them without even

Woman's World7 min read
Health

People with eating disorders are taking GLP-1s, and doctors are alarmed

Stevee Williams, a restaurant manager in Houston, was preparing for her sister’s wedding when anxieties bubbled up about how she would look in her bridesmaid dress. She was diagnosed with anorexia when she was 17 and her struggle with eating never left. This time, at 27, she turned to a new tool to control her appetite, one of the GLP-1 drugs fueling a national weight-loss craze. On an online site promising easy prescriptions, she typed that she was 150 pounds (she wasn’t) and indicated she did

Washington Post9 min read237
Health

Ozempic & Friends: How these Shots Affect Muscle Mass

Jill Brown (Jill Brown Fitness) explains what GLP‑1 drugs (like semaglutide, tirzepatide, and newer agents) actually do, who should consider them, and important precautions — especially how rapid appetite suppression can cause muscle loss if you don't prioritize protein and resistance training. She ...

TheStreet11 min read
Health

How Author Mary Kay Andrews, 71, Lost 65 Lbs. Microdosing GLP-1 Meds

If you’ve struggled mightily to lose weight and keep it off long term, bestselling author Mary Kay Andrews, 71, can relate—and she may even give you hope for a healthier future. Because after decades of yo-yoing, she’s down 65 pounds and is maintaining with ease. Her secret? Pairing budget-friendly Costco and yard-sale strategies for protein

Woman's World6 min read
Health

Lilly's Mounjaro tops other GLP-1s for some type 2 diabetes patients

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) May 29 (Reuters) - We also report on two studies with findings that could bring eventual relief for patients still struggling with long COVID symptoms.

Reuters3 min read
Health

The science around GLP-1 drugs and cancer is suddenly getting a lot more interesting

The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the science - and culture - of weight loss. Now a growing body of research is raising another possibility: that these drugs may help protect against cancer.Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. At this year’s American Society of Clinical Oncology (ASCO) meeting in Chicago, more than 40 studies, abstracts, oral

Washington Post8 min read
Health

Retatrutide results spark questions about how rapid weight loss affects the body

Once people understood glucagonlike peptide 1 (GLP-1) drugs’ potential for weight loss, the race among pharmaceutical companies was on. Among the current options, Wegovy can help people lose an average of 10 percent of their body weight in a year, while people taking Zepbound have had about a 15 percent loss, on average, in the same period. Already popular on the online peptide gray market, the new drug, originally developed by Eli Lilly, caused participants in a recent clinical study to lose more than a quarter of their body weight over 80 weeks at the highest dose—results comparable to bariatric surgery.

Scientific American7 min read
Health

Ozempic and Triathlon: A Risky Recipe for Tendon Tears?

New data reveals that the widely used weight-loss drugs GLP-1 receptor agonists are associated with a significantly increased risk of serious tendon injuries - a concerning finding for endurance athletes using the medication, says Dr. Jeffrey Sankoff.

Triathlete5 min read
Health

An experimental GLP-1 pushes the limits of weight loss. There are risks.

Eli Lilly this month unveiled startling new data that showed an experimental weight-loss drug caused people with obesity to shed, on average, 28 percent of their body weight - a substantial step up in potency from the existing crop of GLP-1 medicines. But that breakthrough also is prompting some doctors to urge caution.Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. In interviews, doctors warned that using a drug to shrink your body

Washington Post5 min read
Business

Kroger, Walmart, and Costco face a $6.5 billion GLP-1 problem

Having been taking a GLP-1, tirzepatide, for about five months, I can share how it impacted me, as the experience is not the same for everyone. Taking the drug, which I administer as a shot once a week, has lessened my appetite, but not my desire to eat. For the first few months, it did not really ...

TheStreet5 min read

Comments